Dr. Bojana Turic was a part of the executive team at PMI labs, a Vancouver-based private spin off company from BC Cancer Agency that focused on early cancer detection. She led the company through all steps from a concept through significant clinical and regulatory milestones including positioning the company as a leader in early cancer diagnostic technologies, the development of strategic commercialization alliances, and execution of the company’s first commercial agreements. She was also instrumental for expanding private pathology services in BC.
Dr. Turic completed her MD at the University of Sarajevo, Bosnia, and Herzegovina where she held the position of Assistant Professor of Medical Microbiology. She finished her fellowship in Medical microbiology at the University of Zagreb, Croatia.